SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001655759-24-000097
Filing Date
2024-06-18
Accepted
2024-06-18 17:51:43
Documents
4
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1718747495.html 3  
1 FORM 3 wk-form3_1718747495.xml 3 14252
2 EX-24.1 section_16xpoaxcacacex20.htm EX-24.1 5455
3 section_16xpoaxcacacex20001.jpg GRAPHIC 309123
4 section_16xpoaxcacacex20002.jpg GRAPHIC 40019
  Complete submission text file 0001655759-24-000097.txt   502393
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Issuer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARVINAS, INC. 5 SCIENCE PARK, 395 WINCHESTER AVE. NEW HAVEN CT 06511
Business Address
Cacace Angela M (Reporting) CIK: 0002026306 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38672 | Film No.: 241053326